Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

N-acetylaspartylglutamate in Canavan disease: an adverse effector?

N-acetylaspartylglutamate in Canavan disease: an adverse effector? Eur J Pediatr. 1999 May; 158(5):406-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.